Analyst Ratings for Edwards Lifesciences (EW)
EW Rating Summary
EW Price Target Summary
- Highest: $110.00 (Barclays)
- Lowest: $85.00 (Canaccord)
- Average: $99.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$99.43 (+20.3%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
Avg. $ Target:
$99.43 (+20.3%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/24/2026 | Leerink | Mike Kratky | Upgrade | Outperform (Market Perform) |
101.00 (87.00) |
83.82 (82.63) |
-1.42% | Details |
| 4/1/2026 | Wolfe Research | Mike Polark | Upgrade | Outperform (Peerperform) |
92.00 (N/A) |
80.08 (82.63) |
3.18% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
